Cost Savings Analysis

This analysis confirms our hypothesis that smoking cessation would be the top intervention, with an exceptional Return On Investment (ROI) of 150:1 to 375:1. The data strongly supports prioritizing smoking cessation followed by hypertension control and diabetes management.

Key points:

Smoking cessation is the clear winner because:

• Extremely high smoking rates in prisons (65-80% vs 14% general population)

• Relatively low intervention cost ($200-400)

• Massive long-term savings ($55,000-75,000 per person)

• Benefits begin within 1-2 years

Strategic considerations for a partnership between Prison Healthcare Providers and Managed Care Providers for Medicare and Medicaid patients:

• Evidence suggests 150:1+ ROI for smoking cessation

• Emphasize that cardiovascular benefits start within 1-2 years, making this valuable even for shorter sentences

• The controlled prison environment actually improves quit rates compared to community programs

• Multiple beneficiaries: NaphCare saves on respiratory/cardiovascular care costs immediately, while Centene inherits healthier members upon release

The evidence base is rock-solid with multiple Cochrane reviews and specific prison-based studies.

Our programs are built on a credible, data-driven foundation with supporting evidence to confirm that this isn't just a "sounds good" program but a proven investment strategy that will improve lives and save money.